POVTENZI
Live / Allowed — Publication / registration review complete (as of 10 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 22 Apr 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99779444
- Mark type
- Design + words
- Filed
- 22 Apr 2026
- Published for opposition
- 29 Sept 2026
- Attorney of record
- Lisa M. Tittemore
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immunoglobulin A nephropathy; pharmaceutical preparations for the treatment of primary membranous nephropathy; pharmaceutical preparations for the treatment of lupus nephritis; pharmaceutical preparations for the treatment of renal antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis; pharmaceutical preparations for the treatment of immune thrombocytopenia; pharmaceutical preparations for the treatment of immune thrombocytopenia purpura; pharmaceutical preparations for the treatment of cold autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of warm autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of blood diseases and disorders; pharmaceutical preparations for the treatment of inflammation related diseases and disorders
Owner
- Vertex Pharmaceuticals Incorporated, Boston, MA, US
Prosecution history
- 03 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Aug 2026 — ASSIGNED TO EXAMINER
- 26 Aug 2026 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 26 Aug 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 22 Apr 2026 — APPLICATION FILING RECEIPT MAILED
- 22 Apr 2026 — NEW APPLICATION ENTERED